Related Experiment Video
Updated: Feb 13, 2026

A Rhodopsin Transport Assay by High-Content Imaging Analysis
Published on: January 16, 2019
Ligand channel in pharmacologically stabilized rhodopsin
Daniel Mattle1,2, Bernd Kuhn1, Johannes Aebi1
1Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland.
Abstract:
In the degenerative eye disease retinitis pigmentosa (RP), protein misfolding leads to fatal consequences for cell metabolism and rod and cone cell survival. To stop disease progression, a therapeutic approach focuses on stabilizing inherited protein mutants of the G protein-coupled receptor (GPCR) rhodopsin using pharmacological chaperones (PC) that improve receptor folding and trafficking. In this study, we discovered stabilizing nonretinal small molecules by virtual and thermofluor screening and determined the crystal structure of pharmacologically stabilized opsin at 2.4 Å resolution using one of the stabilizing hits (S-RS1). Chemical modification of S-RS1 and further structural analysis revealed the core binding motif of this class of rhodopsin stabilizers bound at the orthosteric binding site. Furthermore, previously unobserved conformational changes are visible at the intradiscal side of the seven-transmembrane helix bundle. A hallmark of this conformation is an open channel connecting the ligand binding site with the membrane and the intradiscal lumen of rod outer segments. Sufficient in size, the passage permits the exchange of hydrophobic ligands such as retinal. The results broaden our understanding of rhodopsin's conformational flexibility and enable therapeutic drug intervention against rhodopsin-related retinitis pigmentosa.
Insights
Researchers discovered small molecules that stabilize the rhodopsin protein, a key factor in retinitis pigmentosa (RP). This finding offers a new therapeutic strategy for treating this degenerative eye disease by improving protein folding and cell survival.
Area of Science:
- Biochemistry
- Structural Biology
- Ophthalmology
Background:
- Retinitis pigmentosa (RP) is a degenerative eye disease caused by protein misfolding, affecting cell metabolism and photoreceptor survival.
- Current therapeutic strategies for RP aim to stabilize mutant rhodopsin (a G protein-coupled receptor) using pharmacological chaperones (PC) to improve folding and trafficking.
Purpose of the Study:
- To identify novel small molecules that stabilize rhodopsin mutants.
- To elucidate the structural basis of rhodopsin stabilization by small molecules.
Main Methods:
- Virtual screening and thermofluor screening were employed to discover stabilizing small molecules.
- Crystal structure determination of stabilized opsin (using hit S-RS1) at 2.4 Å resolution.
- Chemical modification of a lead compound (S-RS1) and subsequent structural analysis.
Main Results:
- Discovery of nonretinal small molecules that stabilize rhodopsin.
- Determination of the crystal structure revealing the binding motif of stabilizers at the orthosteric site.
- Identification of novel conformational changes in rhodopsin, including an open channel facilitating ligand exchange.
Conclusions:
- The identified small molecules represent a promising therapeutic approach for rhodopsin-related retinitis pigmentosa.
- Understanding rhodopsin's conformational flexibility is crucial for developing effective treatments.
- This work provides a foundation for drug intervention against RP by stabilizing rhodopsin.
More Related Videos
12:08Catalytic Reactions at Amine-Stabilized and Ligand-Free Platinum Nanoparticles Supported on Titania During Hydrogenation of Alkenes and Aldehydes
Published on: June 24, 2022
11:19Site Directed Spin Labeling and EPR Spectroscopic Studies of Pentameric Ligand-Gated Ion Channels
Published on: July 4, 2016
Related Concept Videos
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...